Recombinant human PKC beta 2 protein is a Human Full Length protein, in the 1 to 671 aa range, expressed in Baculovirus infected Sf9, with >70% purity and suitable for SDS-PAGE, FuncS.
>70%
Baculovirus infected Sf9 cells
GST tag N-Terminus
SDS-PAGE, FuncS
Yes
M A D P A A G P P P S E G E E S T V R F A R K G A L R Q K N V H E V K N H K F T A R F F K Q P T F C S H C T D F I W G F G K Q G F Q C Q V C C F V V H K R C H E F V T F S C P G A D K G P A S D D P R S K H K F K I H T Y S S P T F C D H C G S L L Y G L I H Q G M K C D T C M M N V H K R C V M N V P S L C G T D H T E R R G R I Y I Q A H I D R D V L I V L V R D A K N L V P M D P N G L S D P Y V K L K L I P D P K S E S K Q K T K T I K C S L N P E W N E T F R F Q L K E S D K D R R L S V E I W D W D L T S R N D F M G S L S F G I S E L Q K A S V D G W F K L L S Q E E G E Y F N V P V P P E G S E A N E E L R Q K F E R A K I S Q G T K V P E E K T T N T V S K F D N N G N R D R M K L T D F N F L M V L G K G S F G K V M L S E R K G T D E L Y A V K I L K K D V V I Q D D D V E C T M V E K R V L A L P G K P P F L T Q L H S C F Q T M D R L Y F V M E Y V N G G D L M Y H I Q Q V G R F K E P H A V F Y A A E I A I G L F F L Q S K G I I Y R D L K L D N V M L D S E G H I K I A D F G M C K E N I W D G V T T K T F C G T P D Y I A P E I I A Y Q P Y G K S V D W W A F G V L L Y E M L A G Q A P F E G E D E D E L F Q S I M E H N V A Y P K S M S K E A V A I C K G L M T K H P G K R L G C G P E G E R D I K E H A F F R Y I D W E K L E R K E I Q P P Y K P K A C G R N A E N F D R F F T R H P P V L T P P D Q E V I R N I D Q S E F E G F S F V N S E F L K P E V K S
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application FuncS | Reactivity Reacts | Dilution info - | Notes - |
Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase involved in various cellular processes such as regulation of the B-cell receptor (BCR) signalosome, oxidative stress-induced apoptosis, androgen receptor-dependent transcription regulation, insulin signaling and endothelial cells proliferation. Plays a key role in B-cell activation by regulating BCR-induced NF-kappa-B activation. Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11/CARMA1 at 'Ser-559', 'Ser-644' and 'Ser-652'. Phosphorylation induces CARD11/CARMA1 association with lipid rafts and recruitment of the BCL10-MALT1 complex as well as MAP3K7/TAK1, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. Plays a direct role in the negative feedback regulation of the BCR signaling, by down-modulating BTK function via direct phosphorylation of BTK at 'Ser-180', which results in the alteration of BTK plasma membrane localization and in turn inhibition of BTK activity (PubMed:11598012). Involved in apoptosis following oxidative damage: in case of oxidative conditions, specifically phosphorylates 'Ser-36' of isoform p66Shc of SHC1, leading to mitochondrial accumulation of p66Shc, where p66Shc acts as a reactive oxygen species producer. Acts as a coactivator of androgen receptor (AR)-dependent transcription, by being recruited to AR target genes and specifically mediating phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag for epigenetic transcriptional activation that prevents demethylation of histone H3 'Lys-4' (H3K4me) by LSD1/KDM1A (PubMed:20228790). In insulin signaling, may function downstream of IRS1 in muscle cells and mediate insulin-dependent DNA synthesis through the RAF1-MAPK/ERK signaling cascade. Participates in the regulation of glucose transport in adipocytes by negatively modulating the insulin-stimulated translocation of the glucose transporter SLC2A4/GLUT4. Phosphorylates SLC2A1/GLUT1, promoting glucose uptake by SLC2A1/GLUT1 (PubMed:25982116). Under high glucose in pancreatic beta-cells, is probably involved in the inhibition of the insulin gene transcription, via regulation of MYC expression. In endothelial cells, activation of PRKCB induces increased phosphorylation of RB1, increased VEGFA-induced cell proliferation, and inhibits PI3K/AKT-dependent nitric oxide synthase (NOS3/eNOS) regulation by insulin, which causes endothelial dysfunction. Also involved in triglyceride homeostasis (By similarity). Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription (PubMed:19176525). Phosphorylates KLHL3 in response to angiotensin II signaling, decreasing the interaction between KLHL3 and WNK4 (PubMed:25313067). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231).
PKCB, PRKCB1, PRKCB1, PRKCB, PKCB, Protein kinase C beta type, PKC-B, PKC-beta
Recombinant human PKC beta 2 protein is a Human Full Length protein, in the 1 to 671 aa range, expressed in Baculovirus infected Sf9, with >70% purity and suitable for SDS-PAGE, FuncS.
>70%
Baculovirus infected Sf9 cells
GST tag N-Terminus
SDS-PAGE, FuncS
Yes
423 nmol/min/mg Specific activity defined by radiometric assay, nmol of gamma-phosphate from ATP transferred to PKCtide peptide substrate
No
Human
pH: 7.5
Constituents: 25% Glycerol (glycerin, glycerine), 0.87% Sodium chloride, 0.79% Tris HCl, 0.31% Glutathione, 0.00385% (R*,R*)-1,4-Dimercaptobutan-2,3-diol, 0.00292% EDTA, 0.00174% PMSF
M A D P A A G P P P S E G E E S T V R F A R K G A L R Q K N V H E V K N H K F T A R F F K Q P T F C S H C T D F I W G F G K Q G F Q C Q V C C F V V H K R C H E F V T F S C P G A D K G P A S D D P R S K H K F K I H T Y S S P T F C D H C G S L L Y G L I H Q G M K C D T C M M N V H K R C V M N V P S L C G T D H T E R R G R I Y I Q A H I D R D V L I V L V R D A K N L V P M D P N G L S D P Y V K L K L I P D P K S E S K Q K T K T I K C S L N P E W N E T F R F Q L K E S D K D R R L S V E I W D W D L T S R N D F M G S L S F G I S E L Q K A S V D G W F K L L S Q E E G E Y F N V P V P P E G S E A N E E L R Q K F E R A K I S Q G T K V P E E K T T N T V S K F D N N G N R D R M K L T D F N F L M V L G K G S F G K V M L S E R K G T D E L Y A V K I L K K D V V I Q D D D V E C T M V E K R V L A L P G K P P F L T Q L H S C F Q T M D R L Y F V M E Y V N G G D L M Y H I Q Q V G R F K E P H A V F Y A A E I A I G L F F L Q S K G I I Y R D L K L D N V M L D S E G H I K I A D F G M C K E N I W D G V T T K T F C G T P D Y I A P E I I A Y Q P Y G K S V D W W A F G V L L Y E M L A G Q A P F E G E D E D E L F Q S I M E H N V A Y P K S M S K E A V A I C K G L M T K H P G K R L G C G P E G E R D I K E H A F F R Y I D W E K L E R K E I Q P P Y K P K A C G R N A E N F D R F F T R H P P V L T P P D Q E V I R N I D Q S E F E G F S F V N S E F L K P E V K S
Full Length
105 kDa
1 to 671
Recombinant
GST tag N-Terminus
Liquid
Purified by affinity chromatography
Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase involved in various cellular processes such as regulation of the B-cell receptor (BCR) signalosome, oxidative stress-induced apoptosis, androgen receptor-dependent transcription regulation, insulin signaling and endothelial cells proliferation. Plays a key role in B-cell activation by regulating BCR-induced NF-kappa-B activation. Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11/CARMA1 at 'Ser-559', 'Ser-644' and 'Ser-652'. Phosphorylation induces CARD11/CARMA1 association with lipid rafts and recruitment of the BCL10-MALT1 complex as well as MAP3K7/TAK1, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. Plays a direct role in the negative feedback regulation of the BCR signaling, by down-modulating BTK function via direct phosphorylation of BTK at 'Ser-180', which results in the alteration of BTK plasma membrane localization and in turn inhibition of BTK activity (PubMed:11598012). Involved in apoptosis following oxidative damage: in case of oxidative conditions, specifically phosphorylates 'Ser-36' of isoform p66Shc of SHC1, leading to mitochondrial accumulation of p66Shc, where p66Shc acts as a reactive oxygen species producer. Acts as a coactivator of androgen receptor (AR)-dependent transcription, by being recruited to AR target genes and specifically mediating phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag for epigenetic transcriptional activation that prevents demethylation of histone H3 'Lys-4' (H3K4me) by LSD1/KDM1A (PubMed:20228790). In insulin signaling, may function downstream of IRS1 in muscle cells and mediate insulin-dependent DNA synthesis through the RAF1-MAPK/ERK signaling cascade. Participates in the regulation of glucose transport in adipocytes by negatively modulating the insulin-stimulated translocation of the glucose transporter SLC2A4/GLUT4. Phosphorylates SLC2A1/GLUT1, promoting glucose uptake by SLC2A1/GLUT1 (PubMed:25982116). Under high glucose in pancreatic beta-cells, is probably involved in the inhibition of the insulin gene transcription, via regulation of MYC expression. In endothelial cells, activation of PRKCB induces increased phosphorylation of RB1, increased VEGFA-induced cell proliferation, and inhibits PI3K/AKT-dependent nitric oxide synthase (NOS3/eNOS) regulation by insulin, which causes endothelial dysfunction. Also involved in triglyceride homeostasis (By similarity). Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription (PubMed:19176525). Phosphorylates KLHL3 in response to angiotensin II signaling, decreasing the interaction between KLHL3 and WNK4 (PubMed:25313067). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231).
Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily.
Phosphorylation on Thr-500 within the activation loop renders it competent to autophosphorylate. Subsequent autophosphorylation of Thr-642 maintains catalytic competence, and autophosphorylation on Ser-661 appears to release the kinase into the cytosol. Autophosphorylation on other sites i.e. in the N-terminal and hinge regions have no effect on enzyme activity. Phosphorylation at Tyr-662 by SYK induces binding with GRB2 and contributes to the activation of MAPK/ERK signaling cascade (By similarity).
Nucleus
Dry Ice
-80°C
-80°C
Upon delivery aliquot
Avoid freeze / thaw cycle
This product is an active protein and may elicit a biological response in vivo, handle with caution.
CREB peptide ab204856 (CREB peptide) can be utilized as a substrate for assessing kinase activity
This supplementary information is collated from multiple sources and compiled automatically.
Protein kinase C beta 2 also known as PKC beta 2 or PRKCB is an important isoform of the PKC family with a molecular weight of 79 kDa. PKC proteins are a group of serine/threonine kinases involved in various cellular processes. PKC beta 2 expresses in tissues like the spleen lymph nodes and other immune-related tissues. The protein plays a significant role in immune responses and its expression is regulated by various signaling molecules.
PKC beta 2 acts as an important regulator in the immune system by modulating immune cell activation and proliferation. It functions as part of the PKC protein complex which interacts with lipids and calcium as cofactors. This protein has critical influence on processes such as B-cell activation and phagocyte response. It also regulates several transcription factors impacting gene expression critical for the immune system.
PKC beta 2 integrates into multiple signaling pathways including the NF-kB and MAPK pathways. These pathways are essential for transmitting signals from the cell surface to the nucleus affecting gene expression and cell function. PKC beta 2 directly influences protein interactions within these pathways such as with other PKC family members and other proteins like IKK which is critical in the NF-kB signaling pathway.
PKC beta 2 is significantly connected to certain cancers and autoimmune conditions. Aberrant PKC beta 2 activity is linked to chronic lymphocytic leukemia where it affects the survival and proliferation of B cells. It is also involved in diabetic nephropathy contributing to kidney damage through excessive signaling. In these conditions PKC beta 2 interacts with proteins like Bcl-2 in cancer and TGF-beta in diabetic nephropathy influencing the disease courses and potentially serving as targets for therapeutic interventions.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking and dilution buffer: 5% NFDM/TBST.
Active human PKC alpha full length protein (Recombinant human PKC alpha protein (Active) ab55672) contains aa1-672 with GST-tag.
Active human PKC beta 1 full length protein (Recombinant human PKC beta 1 protein ab60840) contains aa1-671 with GST-tag.
Active human PKC beta 2 full length protein (ab60841) contains aa1-673 with GST-tag.
Active human PKC delta full length protein (Recombinant human PKC delta protein ab60844) contains aa1-676 with GST-tag.
Active human PKC eta full length protein (Recombinant human PKC eta protein ab60849) contains aa1-683 with GST-tag.
Active human PKC epsilon full length protein (Recombinant human PKC epsilon protein ab60847) contains aa1-737 with GST-tag.
Active human PKC theta full length protein (Recombinant human PKC theta/PRKCQ protein ab56641) contains aa1-706 with GST-tag.
Active human PKC mu full length protein (Recombinant human PKC mu/PKD protein ab60873) contains aa1-912 with GST-tag.
All lanes: Western blot - Anti-PKC (phospho S660) antibody [EP1902Y] (Anti-PKC (phospho S660) antibody [EP1902Y] ab75837) at 1/20000 dilution
Lane 1: Western blot - Recombinant human PKC alpha protein (Active) (Recombinant human PKC alpha protein (Active) ab55672)
Lane 2: Western blot - Recombinant human PKC beta 1 protein (Recombinant human PKC beta 1 protein ab60840)
Lane 3: Western blot - Recombinant human PKC beta 2 protein (ab60841)
Lane 4: Western blot - Recombinant human PKC delta protein (Recombinant human PKC delta protein ab60844)
Lane 5: Western blot - Recombinant human PKC eta protein (Recombinant human PKC eta protein ab60849)
Lane 6: Western blot - Recombinant human PKC epsilon protein (Recombinant human PKC epsilon protein ab60847)
Lane 7: Western blot - Recombinant human PKC theta/PRKCQ protein (Recombinant human PKC theta/PRKCQ protein ab56641)
Lane 8: Western blot - Recombinant human PKC mu/PKD protein (Recombinant human PKC mu/PKD protein ab60873)
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 77 kDa
Observed band size: 100-150 kDa
Exposure time: 1s
Blocking and dilution buffer: 5% NFDM/TBST.
Active human PKC alpha full length protein (Recombinant human PKC alpha protein (Active) ab55672) contains aa1-672 with GST-tag.
Active human PKC beta 1 full length protein (Recombinant human PKC beta 1 protein ab60840) contains aa1-671 with GST-tag.
Active human PKC beta 2 full length protein (ab60841) contains aa1-673 with GST-tag.
Active human PKC delta full length protein (Recombinant human PKC delta protein ab60844) contains aa1-676 with GST-tag.
Active human PKC eta full length protein (Recombinant human PKC eta protein ab60849) contains aa1-683 with GST-tag.
Active human PKC epsilon full length protein (Recombinant human PKC epsilon protein ab60847) contains aa1-737 with GST-tag.
Active human PKC theta full length protein (Recombinant human PKC theta/PRKCQ protein ab56641) contains aa1-706 with GST-tag.
Active human PKC mu full length protein (Recombinant human PKC mu/PKD protein ab60873) contains aa1-912 with GST-tag.
The specific activity of PKC beta 2 (ab60841) was determined to be 423 nmol/min/mg as per activity assay protocol
5% NFDM/TBST
All positive controls 10 ng
All lanes: Western blot - Anti-PKC alpha antibody [133] (Anti-PKC alpha antibody [133] ab11723) at 1/1000 dilution
Lane 1: Western blot - Recombinant human PKC alpha protein (Active) (Recombinant human PKC alpha protein (Active) ab55672)
Lane 2: Western blot - Recombinant human PKC beta 1 protein (Recombinant human PKC beta 1 protein ab60840)
Lane 3: Western blot - Recombinant human PKC beta 2 protein (ab60841)
Lane 4: Western blot - Recombinant human PKC eta protein (Recombinant human PKC eta protein ab60849)
Lane 5: Western blot - Recombinant human PKC epsilon protein (Recombinant human PKC epsilon protein ab60847)
Lane 6: Western blot - Recombinant human PKC theta/PRKCQ protein (Recombinant human PKC theta/PRKCQ protein ab56641)
Lane 7: Western blot - Recombinant human PKC mu/PKD protein (Recombinant human PKC mu/PKD protein ab60873)
Lane 8: Western blot - Recombinant human PKC zeta protein (Recombinant human PKC zeta protein ab60848)
Lane 9: Western blot - Recombinant human PKC iota protein (Recombinant human PKC iota protein ab60850)
Lane 10: Western blot - Recombinant human PKC gamma protein (Recombinant human PKC gamma protein ab60842)
All lanes: Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/5000 dilution
Predicted band size: 76 kDa
SDS PAGE analysis of ab60841
Sample Kinase Activity Plot.
ab60841 on SDS-PAGE, MW ~105 kDa.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PKC alpha antibody [Y124] ab32376).
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
All lanes: Western blot - Anti-PKC alpha antibody [Y124] (Anti-PKC alpha antibody [Y124] ab32376) at 1/2000 dilution
Lane 1: Western blot - Recombinant human PKC alpha protein (Active) (Recombinant human PKC alpha protein (Active) ab55672)
Lane 2: Western blot - Recombinant human PKC beta 1 protein (Recombinant human PKC beta 1 protein ab60840)
Lane 3: Western blot - Recombinant human PKC beta 2 protein (ab60841)
Lane 4: Western blot - Recombinant human PKC gamma protein (Recombinant human PKC gamma protein ab60842)
Lane 5: Western blot - Recombinant human PKC delta protein (Recombinant human PKC delta protein ab60844)
Lane 6: Western blot - Recombinant human PKC epsilon protein (Recombinant human PKC epsilon protein ab60847)
Lane 7: Western blot - Recombinant human PKC zeta protein (Recombinant human PKC zeta protein ab60848)
Lane 8: Western blot - Recombinant human PKC eta protein (Recombinant human PKC eta protein ab60849)
Lane 9: Western blot - Recombinant human PKC theta/PRKCQ protein (Recombinant human PKC theta/PRKCQ protein ab56641)
Lane 10: Western blot - Recombinant human PKC iota protein (Recombinant human PKC iota protein ab60850)
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 76 kDa
Observed band size: 105 kDa
Exposure time: 20s
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
Anti-GST antibody [EPR4236] - BSA and Azide free ab235384 was used to detect GST tag.
All lanes: Western blot - Anti-PKC beta 2 antibody [Y125] (Anti-PKC beta 2 antibody [Y125] ab32026) at 1/1000 dilution
Lane 1: Western blot - Recombinant human PKC beta 2 protein (ab60841) at 10 ng
Lane 2: Western blot - Recombinant human PKC beta 1 protein (Recombinant human PKC beta 1 protein ab60840) at 10 ng
Lane 3: Western blot - Recombinant human PKC delta protein (Recombinant human PKC delta protein ab60844) at 10 ng
Lane 4: Western blot - Recombinant human PKC eta protein (Recombinant human PKC eta protein ab60849) at 10 ng
Lane 5: Western blot - Recombinant human PKC epsilon protein (Recombinant human PKC epsilon protein ab60847) at 10 ng
Lane 6: Western blot - Recombinant human PKC theta/PRKCQ protein (Recombinant human PKC theta/PRKCQ protein ab56641) at 10 ng
Lane 7: Western blot - Recombinant human PKC mu/PKD protein (Recombinant human PKC mu/PKD protein ab60873) at 10 ng
Lane 8: Western blot - Recombinant human PKC alpha protein (Active) (Recombinant human PKC alpha protein (Active) ab55672) at 10 ng
Lane 9: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 10 ng
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 77 kDa
Observed band size: 100 kDa
Blocking and dilution buffer: 5% NFDM/TBST.
Anti-PKC (phospho T514) antibody [EP2730Y] ab109539 could detect PKC gamma (pT514), PKC alpha (pT497), PKC beta (pT500), PKC delta (pT507), PKC eta (pT513), PKC epsilon (pT566) and PKC theta (pT538).
Active human PKC alpha full length protein (Catalog#Recombinant human PKC alpha protein (Active) ab55672) contains aa1-672 with GST-tag;
Active human PKC beta 1 full length protein (Catalog#Recombinant human PKC beta 1 protein ab60840) contains aa1-671 with GST-tag;
Active human PKC beta 2 full length protein (Catalog#ab60841) contains aa1-673 with GST-tag;
Active human PKC delta full length protein (Catalog#Recombinant human PKC delta protein ab60844) contains aa1-676 with GST-tag;
Active human PKC eta full length protein (Catalog#Recombinant human PKC eta protein ab60849) contains aa1-683 with GST-tag;
Active human PKC epsilon full length protein (Catalog#Recombinant human PKC epsilon protein ab60847) contains aa1-737 with GST-tag;
Active human PKC theta full length protein (Catalog#Recombinant human PKC theta/PRKCQ protein ab56641) contains aa1-706 with GST-tag;
Active human PKC mu full length protein (Catalog#Recombinant human PKC mu/PKD protein ab60873) contains aa1-912 with GST-tag;
Active human PKC gamma full length protein (Catalog#Recombinant human PKC gamma protein ab60842) contains aa1-697 with GST-tag.
All lanes: Western blot - Anti-PKC (phospho T514) antibody [EP2730Y] (Anti-PKC (phospho T514) antibody [EP2730Y] ab109539) at 1/1000 dilution
Lane 1: Western blot - Recombinant human PKC alpha protein (Active) (Recombinant human PKC alpha protein (Active) ab55672) at 0.5 µg
Lane 2: Western blot - Recombinant human PKC beta 1 protein (Recombinant human PKC beta 1 protein ab60840) at 0.2 µg
Lane 3: Active human PKC beta 2 full length protein at 0.2 µg
Lane 4: Western blot - Recombinant human PKC delta protein (Recombinant human PKC delta protein ab60844) at 0.05 µg
Lane 5: Western blot - Recombinant human PKC eta protein (Recombinant human PKC eta protein ab60849) at 0.5 µg
Lane 6: Western blot - Recombinant human PKC epsilon protein (Recombinant human PKC epsilon protein ab60847) at 1 µg
Lane 7: Western blot - Recombinant human PKC theta/PRKCQ protein (Recombinant human PKC theta/PRKCQ protein ab56641) at 0.2 µg
Lane 8: Western blot - Recombinant human PKC mu/PKD protein (Recombinant human PKC mu/PKD protein ab60873) at 1 µg
Lane 9: Western blot - Recombinant human PKC gamma protein (Recombinant human PKC gamma protein ab60842) at 0.1 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Predicted band size: 77 kDa
Observed band size: 80 kDa
Exposure time: 180s
This data was developed using Anti-PKC zeta (phospho T410) + PKC iota (phospho T412) antibody [EP1491Y] ab76129, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
Exposure time: Lane 1-4: 180 seconds; Lane 5-6: 60 seconds; Lane 7-10: 5 seconds.
All lanes: Western blot - Anti-PKC zeta (phospho T410) + PKC lambda (phospho T412) antibody [EP1491Y] (Anti-PKC zeta (phospho T410) + PKC iota (phospho T412) antibody [EP1491Y] ab76129) at 1/1000 dilution
Lane 1: Western blot - Recombinant human PKC alpha protein (Active) (Recombinant human PKC alpha protein (Active) ab55672)
Lane 2: Western blot - Recombinant human PKC beta 1 protein (Recombinant human PKC beta 1 protein ab60840)
Lane 3: Western blot - Recombinant human PKC beta 2 protein (ab60841)
Lane 4: Western blot - Recombinant human PKC gamma protein (Recombinant human PKC gamma protein ab60842)
Lane 5: Western blot - Recombinant human PKC delta protein (Recombinant human PKC delta protein ab60844)
Lane 6: Western blot - Recombinant human PKC epsilon protein (Recombinant human PKC epsilon protein ab60847)
Lane 7: Western blot - Recombinant human PKC zeta protein (Recombinant human PKC zeta protein ab60848)
Lane 8: Western blot - Recombinant human PKC eta protein (Recombinant human PKC eta protein ab60849)
Lane 9: Western blot - Recombinant human PKC theta/PRKCQ protein (Recombinant human PKC theta/PRKCQ protein ab56641)
Lane 10: Western blot - Recombinant human PKC iota protein (Recombinant human PKC iota protein ab60850)
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 105 kDa
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
Exposure time: Lane 1-4: 180 seconds; Lane 5-6: 60 seconds; Lane 7-10: 5 seconds.
This data was developed using Anti-PKC alpha (phospho S657) antibody [EPR1901(2)] ab180848, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
All lanes: Western blot - Anti-PKC alpha (phospho S657) antibody [EPR1901(2)] (Anti-PKC alpha (phospho S657) antibody [EPR1901(2)] ab180848) at 1/1000 dilution
Lane 1: Western blot - Recombinant human PKC alpha protein (Active) (Recombinant human PKC alpha protein (Active) ab55672)
Lane 2: Western blot - Recombinant human PKC beta 1 protein (Recombinant human PKC beta 1 protein ab60840)
Lane 3: Western blot - Recombinant human PKC beta 2 protein (ab60841)
Lane 4: Western blot - Recombinant human PKC gamma protein (Recombinant human PKC gamma protein ab60842)
Lane 5: Western blot - Recombinant human PKC delta protein (Recombinant human PKC delta protein ab60844)
Lane 6: Western blot - Recombinant human PKC epsilon protein (Recombinant human PKC epsilon protein ab60847)
Lane 7: Western blot - Recombinant human PKC zeta protein (Recombinant human PKC zeta protein ab60848)
Lane 8: Western blot - Recombinant human PKC eta protein (Recombinant human PKC eta protein ab60849)
Lane 9: Western blot - Recombinant human PKC theta/PRKCQ protein (Recombinant human PKC theta/PRKCQ protein ab56641)
Lane 10: Western blot - Recombinant human PKC iota protein (Recombinant human PKC iota protein ab60850)
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 76 kDa
Observed band size: 105 kDa
Exposure time: 60s
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-PKC zeta (phospho T560) antibody [EP2037AY] ab62372).
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
All lanes: Western blot - Anti-PKC zeta (phospho T560) antibody [EP2037AY] (Anti-PKC zeta (phospho T560) antibody [EP2037AY] ab62372) at 1/1000 dilution
Lane 1: Western blot - Recombinant human PKC alpha protein (Active) (Recombinant human PKC alpha protein (Active) ab55672)
Lane 2: Western blot - Recombinant human PKC beta 1 protein (Recombinant human PKC beta 1 protein ab60840)
Lane 3: Western blot - Recombinant human PKC beta 2 protein (ab60841)
Lane 4: Western blot - Recombinant human PKC gamma protein (Recombinant human PKC gamma protein ab60842)
Lane 5: Western blot - Recombinant human PKC delta protein (Recombinant human PKC delta protein ab60844)
Lane 6: Western blot - Recombinant human PKC epsilon protein (Recombinant human PKC epsilon protein ab60847)
Lane 7: Western blot - Recombinant human PKC zeta protein (Recombinant human PKC zeta protein ab60848)
Lane 8: Western blot - Recombinant human PKC eta protein (Recombinant human PKC eta protein ab60849)
Lane 9: Western blot - Recombinant human PKC theta/PRKCQ protein (Recombinant human PKC theta/PRKCQ protein ab56641)
Lane 10: Western blot - Recombinant human PKC iota protein (Recombinant human PKC iota protein ab60850)
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 68 kDa
Observed band size: 105 kDa
Exposure time: 5s
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
This data was developed using Anti-PKC alpha (phospho T638) antibody [E195] ab32502, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
All lanes: Western blot - Anti-PKC alpha (phospho T638) antibody [E195] (Anti-PKC alpha (phospho T638) antibody [E195] ab32502) at 1/1000 dilution
Lane 1: Western blot - Recombinant human PKC alpha protein (Active) (Recombinant human PKC alpha protein (Active) ab55672)
Lane 2: Western blot - Recombinant human PKC beta 1 protein (Recombinant human PKC beta 1 protein ab60840)
Lane 3: Western blot - Recombinant human PKC beta 2 protein (ab60841)
Lane 4: Western blot - Recombinant human PKC gamma protein (Recombinant human PKC gamma protein ab60842)
Lane 5: Western blot - Recombinant human PKC delta protein (Recombinant human PKC delta protein ab60844)
Lane 6: Western blot - Recombinant human PKC zeta protein (Recombinant human PKC zeta protein ab60848)
Lane 7: Western blot - Recombinant human PKC eta protein (Recombinant human PKC eta protein ab60849)
Lane 8: Western blot - Recombinant human PKC theta/PRKCQ protein (Recombinant human PKC theta/PRKCQ protein ab56641)
Lane 9: Western blot - Recombinant human PKC iota protein (Recombinant human PKC iota protein ab60850)
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 76 kDa
Observed band size: 105 kDa
Exposure time: 60s
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
This data was developed using Anti-PKC delta (phospho T507) antibody [EPR1485Y] ab53295, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
All lanes: Western blot - Anti-PKC delta (phospho T507) antibody [EPR1485Y] (Anti-PKC delta (phospho T507) antibody [EPR1485Y] ab53295) at 1/1000 dilution
Lane 1: Western blot - Recombinant human PKC alpha protein (Active) (Recombinant human PKC alpha protein (Active) ab55672)
Lane 2: Western blot - Recombinant human PKC beta 1 protein (Recombinant human PKC beta 1 protein ab60840)
Lane 3: Western blot - Recombinant human PKC beta 2 protein (ab60841)
Lane 4: Western blot - Recombinant human PKC gamma protein (Recombinant human PKC gamma protein ab60842)
Lane 5: Western blot - Recombinant human PKC delta protein (Recombinant human PKC delta protein ab60844)
Lane 6: Western blot - Recombinant human PKC zeta protein (Recombinant human PKC zeta protein ab60848)
Lane 7: Western blot - Recombinant human PKC eta protein (Recombinant human PKC eta protein ab60849)
Lane 8: Western blot - Recombinant human PKC theta/PRKCQ protein (Recombinant human PKC theta/PRKCQ protein ab56641)
Lane 9: Western blot - Recombinant human PKC iota protein (Recombinant human PKC iota protein ab60850)
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 78 kDa
Observed band size: 105 kDa
Exposure time: 180s
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com